Stacey A. Cohen, MD
My work focuses on the influence of genetics on high-risk gastrointestinal cancers and cancer treatment. I became motivated to participate in research after learning of the number of younger people diagnosed with cancer every year. I’d like to improve screening and early-detection methods, improve recognition of familial cancers and better understand cancers in people diagnosed at an early age. These things take time, but I expect doctors will soon be using much more advanced diagnostic techniques to better select treatments for individual patients, and I hope this will lead to more benefit and fewer side effects from each treatment given.
Being in oncology gives me a chance to establish deep and long-term relationships with my patients. I consider it an honor to be a part of your life at such a difficult and impactful time. My aim is to always treat you with respect and compassion, maintaining an open and honest relationship. As your physician, I appreciate the opportunity to both teach and learn from you as we work together to navigate difficult decisions. I learn so much from my patients, and it motivates me to continue in this field.
Specialty: Medical Oncology
As a medical oncologist who specializes in treating people with gastrointestinal (GI) cancers at Fred Hutch, my areas of expertise include colorectal, pancreatic and anal cancers, early onset cancers and hereditary cancers. I’m also a UW assistant professor of medicine in the Division of Oncology.
Hyperthermic intraperitoneal chemotherapy (HIPEC) provides an important treatment option that can improve survival for some patients with advanced peritoneal cancer. Managing this disease — and determining whether and when to use HIPEC — requires an experienced, coordinated team of specialists.
It’s a fairly universal experience to feel stuffed to the brim after Thanksgiving dinner. So Angie Ballou wasn’t overly concerned when her stomach started hurting, or even when she threw up after her holiday meal in 2017. “I figured I ate too much,” says Ballou, 47, who was living in Marysville, Washington, at the time.
We make promising new treatments available to you through studies called clinical trials led by Fred Hutch doctors. Many of these trials at Fred Hutch have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
Many of our Fred Hutch doctors conduct ongoing research to improve standards of patient care. Their work is evaluated by other doctors and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this Fred Hutch provider has written.
Our providers are often asked to give their medical expertise for press and news publications. Read articles by or about this Fred Hutch provider.
SCCA’s Stacey Cohen, MD was interviewed by OncLive about the importance of patient selection for cytoreductive surgery and HIPEC in colorectal cancer.
SCCA’s Stacey Cohen, MD spoke with OncLive about tailoring colorectal cancer treatments for individual subtypes.
Your care team
Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.